Minister for Health announces changes to international travel requirements
Foilsithe
An t-eolas is déanaí
Teanga: Níl leagan Gaeilge den mhír seo ar fáil.
Foilsithe
An t-eolas is déanaí
Teanga: Níl leagan Gaeilge den mhír seo ar fáil.
The Minister for Health, Stephen Donnelly TD, has signed regulations amending requirements around international travel to Ireland.
Since 31 October, home quarantine has no longer been required of any category of international traveller. Persons travelling to Ireland continue to be required to have appropriate proof of vaccination or recovery, or to present evidence of a valid RT-PCR test result. With effect from 9 November, further changes will apply to international travel policy:
Persons travelling to Ireland continue to be required to complete a COVID-19 Passenger Locator Form. The form may be used for contact tracing or to contact passengers to provide public health advice.
Regulations having been signed:
Minister Donnelly said:
“Having regard to the epidemiological situation and latest public advice, it is important that we maintain proportionate measures to mitigate the risks associated with travel.
“Regulations I have signed today acknowledge that vaccination policies internationally differ, and that not everyone, including Irish citizens living overseas, can access the vaccine products and doses that we administer domestically.
“The acceptance for travel purposes of additional vaccine products and heterologous doses will mean that many people will be relieved of the requirement to undergo RT-PCR testing when travelling to Ireland.”
The full list of accepted vaccine accepted for travel is:
A full course of any one of the following vaccines: | Regarded as vaccinated after: |
2 doses of Pfizer-BioNTech Vaccine: BNT162b2 (Comirnaty®) | 7 days |
2 doses of Moderna Vaccine: CX-024414 (Moderna®) | 14 days |
2 doses of Oxford-AstraZeneca Vaccine: ChAdOx1-SARS-COV-2 (Vaxzevria® or Covishield) | 15 days |
1 dose of Johnson & Johnson/Janssen Vaccine: Ad26.COV2-S [recombinant] (Janssen®) | 14 days |
2 doses of Coronavac (Sinovac) | 14 days |
2 doses of Sinopharm BIBP | 14 days |
A heterologous (mixed) dose of any of the above vaccines | Apply the information above as it applies to the second dose |
A single dose of any of the above vaccines administered within 180 days of a positive RT-PCR test result. The traveller must hold proof of the positive test and the vaccine dose | Apply the information above as it applies to the administered vaccine |